Biography: Gustavs Latkovskis, MD, PhD is a cardiologist and Professor of Medicine at the University of Latvia. He is one of the key opinion leaders on cardiovascular prevention in Latvia with particular focus on lipids. In 2015, he established the Latvian Registry of Familial Hypercholesterolemia which has collected data on more than 700 individuals and identified more than 350 patients with FH diagnosis and almost 300 patients with possible FH in Latvia. Dr. Latkovskis graduated cum laude in Medicine at the Latvian Medical Academy (currently Riga Stradins University) in 1995 and completed his clinical training in internal medicine and cardiology in Riga, Latvia. He defended PhD thesis at the University of Latvia in 2006 on the topic "Impact of genetic variations of interleukins on the course of coronary heart disease". Dr. Latkovskis has been involved in several clinical trials and published on cardiovascular medicine-related topics, including dyslipidemias, clopidogrel resistance and novel markers. He has co-authored more than 50 publications in international peer-reviewed journals with h-index 15, three national guidelines and three national scientific statements. In Latvia and other Baltic Countries, he is a recognized lecturer on topics such as lipids, hypertension and cardiovascular prevention. He is currently Board Member at the Latvian Society of Cardiology and the Baltic Atherosclerosis Society as well as Board Member and Chairman of the Certification Council of the Latvian Medical Association. He has been president of the Baltic Atherosclerosis Society in 2013-2017. He is also a member of various international societies including ESC, EAS and AHA. In 2019, he was elected as a corresponding member of the Latvian Academy of Sciences.
Day 1 - 03.12.2021 |
|
---|---|
09:30 - 09:45 |
Plenary session, Small Hall
Opening of the conference |
09:45 - 11:15 |
Plenary session, Small Hall
S1 - Aggressive combination treatment of dyslipidemias |
11:45 - 13:15 |
Plenary session, Small Hall
S2 - Early atherosclerosis, hypertension and personalised prevention |
16:05 - 17:05 |
Plenary session, Small Hall
S4 - Prevention of atherosclerosis and heart failure in patients with type 2 diabetes |
Day 2 - 04.12.2021 |
|
---|---|
11:45 - 12:50 |
Plenary session, Small Hall
S7 - Familial hypercholesterolemia registries in Baltic countries |